Skip to content
TrustList
Vivo Capital logo
Investor

Vivo Capital

Vivo Capital

Write a review
Visit WebsiteRequest a demo / quoteWrite a Review
Own this listing? Claim it
Vivo Capital cover

About Vivo Capital

Vivo’s Three Fund Vehicles

ScienTech Medical Technology, a Vivo Capital portfolio company, Successfully Lists on the Main Board of Hong Kong Stock Exchange
Vivo Capital Invests in Zenas Biopharma’s $118 Million Financing to Advance the Company’s Broad Pipeline of Autoimmune Disease Therapeutics
NMPA Approves Suzhou Omni’s Compound Ipratropium Bromide Solution for Inhalation to Treat Symptoms of COPD and Asthma
FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older

Categories & features

Request a demo or quote from Vivo Capital

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

By sending, you agree we may share your request and contact details with the provider once you confirm your email.

Reviews

Write the first review of Vivo Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Vivo Capital.

Vivo Capital alternatives

Similar listings buyers compare against this one.

Compare side by side
Keep exploring

More on TrustList

Everything here links back to the same verified catalogue. Pick your next stop.